Investing@jcutrer.com

Final Glance: Pharmaceuticals companies (AP) Wednesday, 3 December 2008, 4:55 pm

[$$] Study Says Zetia May Help Fight Heart Disease (at The Wall Street Journal Online) Wednesday, 3 December 2008, 4:39 pm

More Job Cuts at Sanofi, This Time in the US (at The Wall Street Journal Online) Wednesday, 3 December 2008, 4:07 pm

Statins, Zetia reverse atherosclerosis in study (at Reuters) Wednesday, 3 December 2008, 4:00 pm

The January Effect Won't Save You (at Motley Fool) Wednesday, 3 December 2008, 2:00 pm

Merck Seeks to Regain Industry Leadership, but Shares Languish (at The Wall Street Journal Online) Wednesday, 3 December 2008, 1:47 pm

Midday Glance: Pharmaceuticals companies (AP) Wednesday, 3 December 2008, 1:23 pm

Early Glance: Pharmaceuticals companies (AP) Wednesday, 3 December 2008, 9:53 am

UPDATE - Schering plans anesthesia drug study after setback (at Reuters) Wednesday, 3 December 2008, 9:02 am

Merck Faces Another Tough Year (at Forbes.com) Wednesday, 3 December 2008, 5:00 am

Final Glance: Pharmaceuticals companies (AP) Tuesday, 2 December 2008, 4:44 pm

Midday Glance: Pharmaceuticals companies (AP) Tuesday, 2 December 2008, 12:44 pm

[$$] The Market Overshoots Once Again (at RealMoney by TheStreet.com) Tuesday, 2 December 2008, 12:34 pm

Early Glance: Pharmaceuticals companies (AP) Tuesday, 2 December 2008, 9:50 am

Health-Care Stocks: The Obama Effect (at BusinessWeek) Tuesday, 2 December 2008, 7:08 am

Final Glance: Pharmaceuticals companies (AP) Monday, 1 December 2008, 4:43 pm

Last month to switch to 'green' asthma inhalers (AP) Monday, 1 December 2008, 2:29 pm

Last warning: Asthma inhalers go "green" on Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch.

Midday Glance: Pharmaceuticals companies (AP) Monday, 1 December 2008, 12:34 pm

Early Glance: Pharmaceuticals companies (AP) Monday, 1 December 2008, 9:35 am

Sanofi-Aventis cutting US sales force by less than 10% Wednesday, 3 December 2008, 1:44 pm

Sanofi-Aventis is reducing its U.S. sales force by less than 10%, continuing a series of layoffs of sales representatives in the beleaguered pharmaceutical industry. The Paris-based drug maker said an unspecified number of its approximately 6,500 U.S. sales representatives have been notified their positions were being eliminated, and the process is ongoing. Spokesman Marc Greene told Dow Jones Newswires Wednesday the number of layoffs amounted to the single-digits on a percentage basis, but he declined to be more specific.

Source: MarketWatch.com - All MarketWatch News - SGP |

Pfizer pulls E.U. application to sell Viagra over the counter Thursday, 20 November 2008, 6:46 am

Pfizer on Thursday said it withdrew an application to sell Viagra without a prescription in Europe after regulators fretted about the safety implications.

Source: MarketWatch.com - All MarketWatch News - SGP |

Audio: Larson: Recessionary conditions require focus on strong, leading companies Thursday, 13 November 2008, 3:35 am

Paul Larson, editor of the Morningstar Stock Investor newsletter, says that the current market environment makes it "a lot more difficult to nail down a fair-value estimate ... than it would be in what you might call a normalized environment, because we don't know just how bad this recession is going to get or how long it is going to last." Larson said that with expectations being for a longer, deeper recession than in the past, investors will want to focus on stocks with strong balance sheets and leading position in their industry."

Source: MarketWatch.com - All MarketWatch News - SGP |

Merck says it will stay in heart research Saturday, 8 November 2008, 7:00 am

Source: MarketWatch.com - All MarketWatch News - SGP |

Biotech Stocks: Drug stocks rocket with broader market rally Tuesday, 28 October 2008, 5:39 pm

Drug stocks rally as the broader market warms on hopes that the Federal Reserve will soon move to further lower interest rates.

Source: MarketWatch.com - All MarketWatch News - SGP |

Biotech Stocks: Drug stocks wallow in negative territory Wednesday, 22 October 2008, 2:02 pm

Drug stocks remain in the red, along with the broader market, as shares of all of the major U.S.-traded pharmaceutical companies lose ground.

Source: MarketWatch.com - All MarketWatch News - SGP |

Merck reports lower quarterly net, sales; more job cuts set Wednesday, 22 October 2008, 9:29 am

Merck & Co. posts third-quarter net earnings that contracted by nearly 30% from a year ago, weighed down by heavy restructuring costs and lackluster pharmaceutical sales.

Source: MarketWatch.com - All MarketWatch News - SGP |

Schering-Plough quarterly profit down 23%, sales up 64% Tuesday, 21 October 2008, 7:01 am

LONDON (MarketWatch) -- Schering-Plough said that third-quarter net profit dropped to $551 million, or 34 cents a share, from $713 million, or 45 cents a share, a year ago. Earnings per share would have been 39 cents on a reconciled basis, up from 28 cents a year ago. Analysts had been expecting earnings of 31 cents a share, according to data compiled by FactSet. Sales jumped to $4.6 billion, from $2.8 billion last year, boosted by the inclusion of net sales from recently acquired Organon BioSciences as well as foreign exchange moves. Global pharmaceutical sales totaled $3.5 billion. "Our performance this quarter again demonstrates the strength of our long-term strategies and our ability to execute on them," said Fred Hassan, chairman and CEO.

Source: MarketWatch.com - All MarketWatch News - SGP |

Schering-Plough: cholesterol JV sales were $1.1B in Q3 Tuesday, 21 October 2008, 6:53 am

Source: MarketWatch.com - All MarketWatch News - SGP |

Schering-Plough adjusted Q3 earnings were 39C Tuesday, 21 October 2008, 6:51 am

Source: MarketWatch.com - All MarketWatch News - SGP |

Sanofi-Aventis Cutting US Sales Force By Less Than 10% Wednesday, 3 December 2008, 1:55 pm

(Source: Dow Jones Business News)

UPDATE: Schering Sees 5 New Drug Applications In 2009 Monday, 24 November 2008, 3:05 pm

(Source: Dow Jones Business News)

Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects Monday, 24 November 2008, 12:01 pm

(Source: PR Newswire)

Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C Monday, 24 November 2008, 10:22 am

(Source: PR Newswire)

Schering-Plough Sees 5 New Drug Applications In 2009 Monday, 24 November 2008, 9:54 am

(Source: Dow Jones Business News)

Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention Monday, 24 November 2008, 9:35 am

(Source: PR Newswire)

Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease Monday, 24 November 2008, 9:35 am

(Source: PR Newswire)

US EQUITIES WEEK AHEAD:Retailers' 3Q Results, Home-Sales Data Friday, 21 November 2008, 1:41 pm

(Source: Dow Jones Business News)

EU Drug Regulator: Schering-Plough Pulls Viraferon Filing Thursday, 20 November 2008, 4:47 am

(Source: Dow Jones Business News)

Seven Summits Research Releases Alerts on RIMM, JPM, SGP, BG, and MR Tuesday, 11 November 2008, 8:31 am

(Source: PR Newswire)

Amid Questions, Merck Says It's Staying In Heart Research Sunday, 9 November 2008, 5:53 pm

(Source: Dow Jones Business News)

US EQUITIES WEEK AHEAD: Retail Results, Heart-Drug Studies Friday, 7 November 2008, 1:47 pm

(Source: Dow Jones Business News)

Schering-Plough to Webcast R&D Update Meeting Friday, 7 November 2008, 10:58 am

(Source: PR Newswire)

UPDATE: Glaxo To Eliminate About 1,800 US Sales Positions Wednesday, 5 November 2008, 11:13 am

(Source: Dow Jones Business News)

Merck: Justice Dept. Is Probing Promotion Of Vytorin Tuesday, 4 November 2008, 8:42 am

(Source: Dow Jones Business News)

Sanofi-Aventis Cutting US Sales Force By Less Than 10% Wednesday, 3 December 2008, 1:55 pm

UPDATE 1-Schering plans anesthesia drug study after setback Wednesday, 3 December 2008, 9:02 am

Schering to conduct new study for anesthesia drug Wednesday, 3 December 2008, 7:59 am

Last month to switch to 'green' asthma inhalers Monday, 1 December 2008, 2:29 pm

Citigroup analyst cuts target for Merck sales, EPS Wednesday, 26 November 2008, 10:39 am

UPDATE 1-Schering-Plough touts drug pipeline 'stars' Monday, 24 November 2008, 1:31 pm

Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Resea... Monday, 24 November 2008, 12:01 pm

Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Pot... Monday, 24 November 2008, 10:21 am

Schering-Plough touts pipeline over competitors' Monday, 24 November 2008, 10:17 am

Schering-Plough touts drug pipeline "stars" Monday, 24 November 2008, 10:15 am

Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding T... Monday, 24 November 2008, 9:35 am

Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrat... Monday, 24 November 2008, 9:35 am

Correction: Merck ratings Wednesday, 19 November 2008, 3:44 pm

International pharma group names leadership Wednesday, 19 November 2008, 1:47 pm

Fitch cuts Merck debt outlook to 'Negative' Monday, 17 November 2008, 5:10 pm

UPDATE 2-Doctors debate Vytorin cancer risk at heart meeting Wednesday, 12 November 2008, 3:04 pm

7 investing themes for tough times Tuesday, 11 November 2008, 9:22 am

Seven Summits Research Releases Alerts on RIMM, JPM, SGP, BG, and MR Tuesday, 11 November 2008, 8:31 am

Midday Glance: Pharmaceuticals companies Friday, 7 November 2008, 1:07 pm

Cholesterol studies highlight heart conference Friday, 7 November 2008, 12:21 pm

Merck: More lawsuits, Justice probe over Vytorin Tuesday, 4 November 2008, 3:14 pm

Final Glance: Pharmaceuticals companies Monday, 3 November 2008, 4:38 pm

Sector Snap: Vertex get boost from hep C drug Monday, 3 November 2008, 11:18 am

Cholesterol drug Vytorin fails Monday, 21 July 2008, 4:31 pm

Patent worries plague pharma Thursday, 24 April 2008, 3:33 pm

Merck accused of research fraud Thursday, 17 April 2008, 10:17 am

The Schering-Plough cure Thursday, 3 April 2008, 12:04 pm

Studs and Duds: Losers Tuesday, 1 April 2008, 4:13 pm

Monday's rewind Monday, 31 March 2008, 4:53 pm

Merck and Schering's setback Monday, 31 March 2008, 10:42 am

Pharma in focus Wednesday, 13 February 2008, 10:40 am

Monsanto's budding outlook Tuesday, 12 February 2008, 12:18 pm

Mixed diagnosis for pharma Thursday, 31 January 2008, 9:03 am

Trouble for pharma Wednesday, 30 January 2008, 10:37 am

Shakeup at Sears Monday, 28 January 2008, 11:44 am